Novartis Germany

Nuremberg

0 studies enrolling now · 1 studies all time

What they study most

Amyotrophic Lateral Sclerosis

Studies at this site

• Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed